| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0052 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |